Since leptin level, signaling, and genetic variation are well known to be correlated with both obesity and colorectal cancer (CRC), obesity, which might be related to tumor molecular subtype, could be a potential interfering factor in CRC survival, indicating leptin as a potential marker for such purposes. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.